{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:13:34Z","timestamp":1791288814975,"version":"4.3.0"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Clinical and genetic research links altered cholesterol metabolism with ALS development and progression, yet pinpointing specific pathomechanisms remain challenging. We investigated how cholesterol dysmetabolism interacts with protein aggregation, demyelination, and neuronal loss in ALS. Bulk RNAseq transcriptomics showed decreased cholesterol biosynthesis and increased cholesterol export in ALS mouse models (GA-Nes, GA-Camk2a GA-CFP, rNLS8) and patient samples (spinal cord), suggesting an adaptive response to cholesterol overload. Consequently, we assessed the efficacy of the cholesterol-binding drug 2-hydroxypropyl-\u03b2-cyclodextrin (CD) in a fast-progressing C9orf72 ALS mouse model with extensive poly-GA expression and myelination deficits. CD treatment normalized cholesteryl ester levels, lowered neurofilament light chain levels, and prolonged lifespan in female but not male GA-Nes mice, without impacting poly-GA aggregates. Single nucleus transcriptomics indicated that CD primarily affected oligodendrocytes, significantly restored myelin gene expression, increased density of myelinated axons, inhibited the disease-associated oligodendrocyte response, and downregulated the lipid-associated genes Plin4 and ApoD. These results suggest that reducing excess free cholesterol in the CNS could be a viable ALS treatment strategy.<\/jats:p>","DOI":"10.1038\/s41467-025-58634-4","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T06:48:01Z","timestamp":1744354081000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Correction of dysregulated lipid metabolism normalizes gene expression in oligodendrocytes and prolongs lifespan in female poly-GA C9orf72 mice"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8974-1304","authenticated-orcid":false,"given":"Ali","family":"Rezaei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vir\u00e1g","family":"Kocsis-Jutka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4720-8226","authenticated-orcid":false,"given":"Zeynep I.","family":"Gunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0574-1310","authenticated-orcid":false,"given":"Qing","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6559-7421","authenticated-orcid":false,"given":"Georg","family":"Kislinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz","family":"Bauernschmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3369-1453","authenticated-orcid":false,"given":"Huseyin Berkcan","family":"Isilgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura R.","family":"Parisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tu\u011fberk","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6374-4910","authenticated-orcid":false,"given":"S\u00f6ren","family":"Franzenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Koppenbrink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Knogler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Arzberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Farny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Nuscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eszter","family":"Katona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashutosh","family":"Dhingra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4644-8252","authenticated-orcid":false,"given":"Garyfallia","family":"Gouna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5052-2972","authenticated-orcid":false,"given":"Katherine D.","family":"LaClair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandar","family":"Janjic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Enard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5733-9820","authenticated-orcid":false,"given":"Qihui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nellwyn","family":"Hagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2348-3642","authenticated-orcid":false,"given":"Dimitry","family":"Ofengeim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7266-4098","authenticated-orcid":false,"given":"Eduardo","family":"Beltr\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozgun","family":"Gokce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5329-192X","authenticated-orcid":false,"given":"Mikael","family":"Simons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5633-8981","authenticated-orcid":false,"given":"Sabine","family":"Liebscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7186-4653","authenticated-orcid":false,"given":"Dieter","family":"Edbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,11]]},"reference":[{"key":"58634_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.71","volume":"3","author":"O Hardiman","year":"2017","unstructured":"Hardiman, O. et al. Amyotrophic lateral sclerosis. Nat. Rev. Dis. Prim. 3, 17071 (2017).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"58634_CR2","doi-asserted-by":"crossref","unstructured":"Feldman E. L. et al. Amyotrophic Lateral Sclerosis (Lancet, 2022).","DOI":"10.1016\/S0140-6736(22)01272-7"},{"key":"58634_CR3","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s00401-013-1181-y","volume":"126","author":"IR Mackenzie","year":"2013","unstructured":"Mackenzie, I. R. et al. Dipeptide repeat protein pathology in C9ORF72 mutation cases: clinico-pathological correlations. Acta Neuropathol. 126, 859\u2013879 (2013).","journal-title":"Acta Neuropathol."},{"key":"58634_CR4","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/01.jnen.0000248554.45456.58","volume":"66","author":"M Neumann","year":"2007","unstructured":"Neumann, M. et al. TDP-43-positive white matter pathology in frontotemporal lobar degeneration with ubiquitin-positive inclusions. J. Neuropathol. Exp. Neurol. 66, 177\u2013183 (2007).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"58634_CR5","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s00401-011-0907-y","volume":"122","author":"ME Murray","year":"2011","unstructured":"Murray, M. E. et al. Clinical and neuropathologic heterogeneity of c9FTD\/ALS associated with hexanucleotide repeat expansion in C9ORF72. Acta Neuropathol. 122, 673\u2013690 (2011).","journal-title":"Acta Neuropathol."},{"key":"58634_CR6","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s00401-013-1189-3","volume":"126","author":"K Mori","year":"2013","unstructured":"Mori, K. et al. Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins. Acta Neuropathol. 126, 881\u2013893 (2013).","journal-title":"Acta Neuropathol."},{"key":"58634_CR7","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1126\/science.1232927","volume":"339","author":"K Mori","year":"2013","unstructured":"Mori, K. et al. The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD\/ALS. Science 339, 1335\u20131338 (2013).","journal-title":"Science"},{"key":"58634_CR8","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.neuron.2013.02.004","volume":"77","author":"PE Ash","year":"2013","unstructured":"Ash, P. E. et al. Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD\/ALS. Neuron 77, 639\u2013646 (2013).","journal-title":"Neuron"},{"key":"58634_CR9","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s00401-013-1192-8","volume":"126","author":"TF Gendron","year":"2013","unstructured":"Gendron, T. F. et al. Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD\/ALS. Acta Neuropathol. 126, 829\u2013844 (2013).","journal-title":"Acta Neuropathol."},{"key":"58634_CR10","doi-asserted-by":"publisher","first-page":"E4968","DOI":"10.1073\/pnas.1315438110","volume":"110","author":"T Zu","year":"2013","unstructured":"Zu, T. et al. RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia. Proc. Natl. Acad. Sci. USA 110, E4968\u2013E4977 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"58634_CR11","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2019102811","volume":"39","author":"B Khosravi","year":"2020","unstructured":"Khosravi, B. et al. Cell-to-cell transmission of C9orf72 poly-(Gly-Ala) triggers key features of ALS\/FTD. EMBO J. 39, e102811 (2020).","journal-title":"EMBO J."},{"key":"58634_CR12","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1093\/brain\/awad351","volume":"147","author":"A Northall","year":"2024","unstructured":"Northall, A. et al. Multimodal layer modelling reveals in vivo pathology in amyotrophic lateral sclerosis. Brain 147, 1087\u20131099 (2024).","journal-title":"Brain"},{"key":"58634_CR13","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/nn.3357","volume":"16","author":"SH Kang","year":"2013","unstructured":"Kang, S. H. et al. Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis. Nat. Neurosci. 16, 571\u2013579 (2013).","journal-title":"Nat. Neurosci."},{"key":"58634_CR14","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1038\/s41593-022-01104-7","volume":"25","author":"M Kenigsbuch","year":"2022","unstructured":"Kenigsbuch, M. et al. A shared disease-associated oligodendrocyte signature among multiple CNS pathologies. Nat. Neurosci. 25, 876\u2013886 (2022).","journal-title":"Nat. Neurosci."},{"key":"58634_CR15","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41586-022-05439-w","volume":"611","author":"JW Blanchard","year":"2022","unstructured":"Blanchard, J. W. et al. APOE4 impairs myelination via cholesterol dysregulation in oligodendrocytes. Nature 611, 769\u2013779 (2022).","journal-title":"Nature"},{"key":"58634_CR16","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.cell.2020.06.038","volume":"182","author":"WT Chen","year":"2020","unstructured":"Chen, W. T. et al. Spatial transcriptomics and in situ sequencing to study Alzheimer\u2019s disease. Cell 182, 976\u2013991 e919 (2020).","journal-title":"Cell"},{"key":"58634_CR17","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s40478-024-01893-x","volume":"12","author":"M Horiuchi","year":"2024","unstructured":"Horiuchi, M. et al. ALS-linked mutant TDP-43 in oligodendrocytes induces oligodendrocyte damage and exacerbates motor dysfunction in mice. Acta Neuropathol. Commun. 12, 184 (2024).","journal-title":"Acta Neuropathol. Commun."},{"key":"58634_CR18","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1038\/s41591-018-0236-y","volume":"24","author":"AM Falcao","year":"2018","unstructured":"Falcao, A. M. et al. Disease-specific oligodendrocyte lineage cells arise in multiple sclerosis. Nat. Med. 24, 1837\u20131844 (2018).","journal-title":"Nat. Med."},{"key":"58634_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111189","volume":"40","author":"S Pandey","year":"2022","unstructured":"Pandey, S. et al. Disease-associated oligodendrocyte responses across neurodegenerative diseases. Cell Rep. 40, 111189 (2022).","journal-title":"Cell Rep."},{"key":"58634_CR20","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41591-019-0695-9","volume":"26","author":"Y Zhou","year":"2020","unstructured":"Zhou, Y. et al. Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer\u2019s disease. Nat. Med. 26, 131\u2013142 (2020).","journal-title":"Nat. Med."},{"key":"58634_CR21","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1038\/s41593-022-01183-6","volume":"25","author":"T Kaya","year":"2022","unstructured":"Kaya, T. et al. CD8(+) T cells induce interferon-responsive oligodendrocytes and microglia in white matter aging. Nat. Neurosci. 25, 1446\u20131457 (2022).","journal-title":"Nat. Neurosci."},{"key":"58634_CR22","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1152\/physrev.00031.2018","volume":"99","author":"C Stadelmann","year":"2019","unstructured":"Stadelmann, C., Timmler, S., Barrantes-Freer, A. & Simons, M. Myelin in the central nervous system: structure, function, and pathology. Physiol. Rev. 99, 1381\u20131431 (2019).","journal-title":"Physiol. Rev."},{"key":"58634_CR23","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1126\/science.aan4183","volume":"359","author":"L Cantuti-Castelvetri","year":"2018","unstructured":"Cantuti-Castelvetri, L. et al. Defective cholesterol clearance limits remyelination in the aged central nervous system. Science 359, 684\u2013688 (2018).","journal-title":"Science"},{"key":"58634_CR24","doi-asserted-by":"publisher","first-page":"333ra350","DOI":"10.1126\/scitranslmed.aad6100","volume":"8","author":"S Zimmer","year":"2016","unstructured":"Zimmer, S. et al. Cyclodextrin promotes atherosclerosis regression via macrophage reprogramming. Sci. Transl. Med. 8, 333ra350 (2016).","journal-title":"Sci. Transl. Med."},{"key":"58634_CR25","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1248\/bpb.b14-00726","volume":"38","author":"Y Tanaka","year":"2015","unstructured":"Tanaka, Y. et al. Efficacy of 2-hydroxypropyl-beta-cyclodextrin in Niemann-Pick disease Type C model mice and its pharmacokinetic analysis in a patient with the disease. Biol. Pharm. Bull. 38, 844\u2013851 (2015).","journal-title":"Biol. Pharm. Bull."},{"key":"58634_CR26","doi-asserted-by":"publisher","first-page":"7688","DOI":"10.1111\/febs.16175","volume":"289","author":"H Hartmann","year":"2022","unstructured":"Hartmann, H., Ho, W. Y., Chang, J. C. & Ling, S. C. Cholesterol dyshomeostasis in amyotrophic lateral sclerosis: cause, consequence, or epiphenomenon? FEBS J. 289, 7688\u20137709 (2022).","journal-title":"FEBS J."},{"key":"58634_CR27","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1002\/ana.24936","volume":"81","author":"D Mariosa","year":"2017","unstructured":"Mariosa, D. et al. Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: a more than 20-year follow-up of the Swedish AMORIS cohort. Ann. Neurol. 81, 718\u2013728 (2017).","journal-title":"Ann. Neurol."},{"key":"58634_CR28","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1136\/jnnp-2021-327133","volume":"93","author":"AG Thompson","year":"2022","unstructured":"Thompson, A. G., Talbot, K. & Turner, M. R. Higher blood high density lipoprotein and apolipoprotein A1 levels are associated with reduced risk of developing amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry 93, 75\u201381 (2022).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"58634_CR29","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1212\/01.wnl.0000285080.70324.27","volume":"70","author":"L Dupuis","year":"2008","unstructured":"Dupuis, L. et al. Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurology 70, 1004\u20131009 (2008).","journal-title":"Neurology"},{"key":"58634_CR30","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s10654-017-0318-z","volume":"32","author":"RS Peter","year":"2017","unstructured":"Peter, R. S. et al. Life course body mass index and risk and prognosis of amyotrophic lateral sclerosis: results from the ALS registry Swabia. Eur. J. Epidemiol. 32, 901\u2013908 (2017).","journal-title":"Eur. J. Epidemiol."},{"key":"58634_CR31","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1474-4422(10)70224-6","volume":"10","author":"L Dupuis","year":"2011","unstructured":"Dupuis, L., Pradat, P. F., Ludolph, A. C. & Loeffler, J. P. Energy metabolism in amyotrophic lateral sclerosis. Lancet Neurol. 10, 75\u201382 (2011).","journal-title":"Lancet Neurol."},{"key":"58634_CR32","doi-asserted-by":"publisher","first-page":"e35333","DOI":"10.1371\/journal.pone.0035333","volume":"7","author":"FP Diekstra","year":"2012","unstructured":"Diekstra, F. P. et al. Mapping of gene expression reveals CYP27A1 as a susceptibility gene for sporadic ALS. PLoS ONE 7, e35333 (2012).","journal-title":"PLoS ONE"},{"key":"58634_CR33","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1038\/s41588-021-00973-1","volume":"53","author":"W van Rheenen","year":"2021","unstructured":"van Rheenen, W. et al. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology. Nat. Genet 53, 1636\u20131648 (2021).","journal-title":"Nat. Genet"},{"key":"58634_CR34","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00401-020-02176-0","volume":"140","author":"KD LaClair","year":"2020","unstructured":"LaClair, K. D. et al. Congenic expression of poly-GA but not poly-PR in mice triggers selective neuron loss and interferon responses found in C9orf72 ALS. Acta Neuropathol. 140, 121\u2013142 (2020).","journal-title":"Acta Neuropathol."},{"key":"58634_CR35","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00401-017-1711-0","volume":"134","author":"MH Schludi","year":"2017","unstructured":"Schludi, M. H. et al. Spinal poly-GA inclusions in a C9orf72 mouse model trigger motor deficits and inflammation without neuron loss. Acta Neuropathol. 134, 241\u2013254 (2017).","journal-title":"Acta Neuropathol."},{"key":"58634_CR36","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s00401-015-1460-x","volume":"130","author":"AK Walker","year":"2015","unstructured":"Walker, A. K. et al. Functional recovery in new mouse models of ALS\/FTLD after clearance of pathological cytoplasmic TDP-43. Acta Neuropathol. 130, 643\u2013660 (2015).","journal-title":"Acta Neuropathol."},{"key":"58634_CR37","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201910919","volume":"12","author":"Q Zhou","year":"2020","unstructured":"Zhou, Q. et al. Active poly-GA vaccination prevents microglia activation and motor deficits in a C9orf72 mouse model. EMBO Mol. Med. 12, e10919 (2020).","journal-title":"EMBO Mol. Med."},{"key":"58634_CR38","doi-asserted-by":"crossref","unstructured":"Esperante, I. J. et al. Testosterone reduces myelin abnormalities in the wobbler mouse model of amyotrophic lateral sclerosis. Biomolecules 14, 428 (2024).","DOI":"10.3390\/biom14040428"},{"key":"58634_CR39","doi-asserted-by":"crossref","unstructured":"Holzmann, C., Witt, M., Rolfs, A., Antipova, V. & Wree, A. Gender-specific effects of two treatment strategies in a mouse model of Niemann-Pick disease type C1. Int. J. Mol. Sci. 22, 2539 (2021).","DOI":"10.3390\/ijms22052539"},{"key":"58634_CR40","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41586-023-06120-6","volume":"618","author":"C Depp","year":"2023","unstructured":"Depp, C. et al. Myelin dysfunction drives amyloid-beta deposition in models of Alzheimer\u2019s disease. Nature 618, 349\u2013357 (2023).","journal-title":"Nature"},{"key":"58634_CR41","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul, H. et al. A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell 169, 1276\u20131290.e1217 (2017).","journal-title":"Cell"},{"key":"58634_CR42","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s00401-014-1329-4","volume":"128","author":"S May","year":"2014","unstructured":"May, S. et al. C9orf72 FTLD\/ALS-associated Gly-Ala dipeptide repeat proteins cause neuronal toxicity and Unc119 sequestration. Acta Neuropathol. 128, 485\u2013503 (2014).","journal-title":"Acta Neuropathol."},{"key":"58634_CR43","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S0896-6273(00)80853-3","volume":"24","author":"L Minichiello","year":"1999","unstructured":"Minichiello, L. et al. Essential role for TrkB receptors in hippocampus-mediated learning. Neuron 24, 401\u2013414 (1999).","journal-title":"Neuron"},{"key":"58634_CR44","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1111\/jnc.15228","volume":"157","author":"AO Sodero","year":"2021","unstructured":"Sodero, A. O. 24S-hydroxycholesterol: cellular effects and variations in brain diseases. J. Neurochem. 157, 899\u2013918 (2021).","journal-title":"J. Neurochem."},{"key":"58634_CR45","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1002\/ana.10312","volume":"52","author":"RG Cutler","year":"2002","unstructured":"Cutler, R. G., Pedersen, W. A., Camandola, S., Rothstein, J. D. & Mattson, M. P. Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress-induced death of motor neurons in amyotrophic lateral sclerosis. Ann. Neurol. 52, 448\u2013457 (2002).","journal-title":"Ann. Neurol."},{"key":"58634_CR46","doi-asserted-by":"publisher","first-page":"9137","DOI":"10.1523\/JNEUROSCI.1388-20.2020","volume":"40","author":"JC Dodge","year":"2020","unstructured":"Dodge, J. C. et al. Neutral lipid cacostasis contributes to disease pathogenesis in amyotrophic lateral sclerosis. J. Neurosci. 40, 9137\u20139147 (2020).","journal-title":"J. Neurosci."},{"key":"58634_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-48059-7","volume":"9","author":"AB Chaves-Filho","year":"2019","unstructured":"Chaves-Filho, A. B. et al. Alterations in lipid metabolism of spinal cord linked to amyotrophic lateral sclerosis. Sci. Rep. 9, 11642 (2019).","journal-title":"Sci. Rep."},{"key":"58634_CR48","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1038\/s41593-022-01199-y","volume":"25","author":"A Zambusi","year":"2022","unstructured":"Zambusi, A. et al. TDP-43 condensates and lipid droplets regulate the reactivity of microglia and regeneration after traumatic brain injury. Nat. Neurosci. 25, 1608\u20131625 (2022).","journal-title":"Nat. Neurosci."},{"key":"58634_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108189","volume":"32","author":"N Thrupp","year":"2020","unstructured":"Thrupp, N. et al. Single-nucleus RNA-Seq is not suitable for detection of microglial activation genes in humans. Cell Rep. 32, 108189 (2020).","journal-title":"Cell Rep."},{"key":"58634_CR50","doi-asserted-by":"crossref","unstructured":"Spiller, K. J. et al. Microglia-mediated recovery from ALS-relevant motor neuron degeneration in a mouse model of TDP-43 proteinopathy. Nat. Neurosci. 21, 329\u2013340 (2018).","DOI":"10.1038\/s41593-018-0083-7"},{"key":"58634_CR51","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s40478-023-01592-z","volume":"11","author":"H Riemenschneider","year":"2023","unstructured":"Riemenschneider, H. et al. Targeting the glycine-rich domain of TDP-43 with antibodies prevents its aggregation in vitro and reduces neurofilament levels in vivo. Acta Neuropathol. Commun. 11, 112 (2023).","journal-title":"Acta Neuropathol. Commun."},{"key":"58634_CR52","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.steroids.2015.02.003","volume":"99","author":"T Nury","year":"2015","unstructured":"Nury, T. et al. Induction of oxiapoptophagy on 158N murine oligodendrocytes treated by 7-ketocholesterol-, 7beta-hydroxycholesterol-, or 24(S)-hydroxycholesterol: protective effects of alpha-tocopherol and docosahexaenoic acid (DHA; C22:6 n-3). Steroids 99, 194\u2013203 (2015).","journal-title":"Steroids"},{"key":"58634_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-80378-y","volume":"11","author":"JC Dodge","year":"2021","unstructured":"Dodge, J. C., Yu, J., Sardi, S. P. & Shihabuddin, L. S. Sterol auto-oxidation adversely affects human motor neuron viability and is a neuropathological feature of amyotrophic lateral sclerosis. Sci. Rep. 11, 803 (2021).","journal-title":"Sci. Rep."},{"key":"58634_CR54","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1242\/jcs.119768","volume":"125","author":"K Hsieh","year":"2012","unstructured":"Hsieh, K. et al. Perilipin family members preferentially sequester to either triacylglycerol-specific or cholesteryl-ester-specific intracellular lipid storage droplets. J. Cell Sci. 125, 4067\u20134076 (2012).","journal-title":"J. Cell Sci."},{"key":"58634_CR55","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00401-020-02164-4","volume":"140","author":"A Ruggieri","year":"2020","unstructured":"Ruggieri, A. et al. Multiomic elucidation of a coding 99-mer repeat-expansion skeletal muscle disease. Acta Neuropathol. 140, 231\u2013235 (2020).","journal-title":"Acta Neuropathol."},{"key":"58634_CR56","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.bbalip.2017.07.009","volume":"1862","author":"C Sztalryd","year":"2017","unstructured":"Sztalryd, C. & Brasaemle, D. L. The perilipin family of lipid droplet proteins: gatekeepers of intracellular lipolysis. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1862, 1221\u20131232 (2017).","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"58634_CR57","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3389\/fnins.2018.00397","volume":"12","author":"X Han","year":"2018","unstructured":"Han, X. et al. Plin4-dependent lipid droplets hamper neuronal mitophagy in the MPTP\/p-Induced mouse model of Parkinson\u2019s disease. Front. Neurosci. 12, 397 (2018).","journal-title":"Front. Neurosci."},{"key":"58634_CR58","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1007\/s12035-020-02217-5","volume":"58","author":"L Zhu","year":"2021","unstructured":"Zhu, L. et al. Perilipin 4 protein: an impending target for amyotrophic lateral sclerosis. Mol. Neurobiol. 58, 1723\u20131737 (2021).","journal-title":"Mol. Neurobiol."},{"key":"58634_CR59","unstructured":"Wang, H. V. et al. Single-nucleus multiome analysis of the prefrontal cortex from C9orf72 ALS\/FTD patients illuminates pathways affected during disease progression. bioRxiv, (2023)."},{"key":"58634_CR60","doi-asserted-by":"crossref","unstructured":"Limone, F. et al. Single-nucleus sequencing reveals enriched expression of genetic risk factors in extratelencephalic neurons sensitive to degeneration in ALS. Nat. Aging 4, 984\u2013997 (2024).","DOI":"10.1038\/s43587-024-00640-0"},{"key":"58634_CR61","doi-asserted-by":"crossref","unstructured":"Lorente Pons, A. et al. Oligodendrocyte pathology exceeds axonal pathology in white matter in human amyotrophic lateral sclerosis. J. Pathol. 251, 262\u2013271 (2020).","DOI":"10.1002\/path.5455"},{"key":"58634_CR62","doi-asserted-by":"crossref","unstructured":"Sirisi, S. et al. Myelin loss in C9orf72 hexanucleotide expansion carriers. J. Neurosci. Res. 100, 1862\u20131875 (2022).","DOI":"10.1002\/jnr.25100"},{"key":"58634_CR63","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1002\/glia.23825","volume":"68","author":"KM Guzman","year":"2020","unstructured":"Guzman, K. M. et al. Conditional depletion of Fus in oligodendrocytes leads to motor hyperactivity and increased myelin deposition associated with Akt and cholesterol activation. Glia 68, 2040\u20132056 (2020).","journal-title":"Glia"},{"key":"58634_CR64","doi-asserted-by":"crossref","unstructured":"Heo, D. et al. Stage-specific control of oligodendrocyte survival and morphogenesis by TDP-43. Elife 11, e75230 (2022).","DOI":"10.7554\/eLife.75230"},{"key":"58634_CR65","doi-asserted-by":"publisher","first-page":"E6496","DOI":"10.1073\/pnas.1607496113","volume":"113","author":"L Ferraiuolo","year":"2016","unstructured":"Ferraiuolo, L. et al. Oligodendrocytes contribute to motor neuron death in ALS via SOD1-dependent mechanism. Proc. Natl. Acad. Sci. USA 113, E6496\u2013E6505 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"58634_CR66","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/s41586-018-0590-4","volume":"562","author":"C Tabula Muris","year":"2018","unstructured":"Tabula Muris, C. et al. Single-cell transcriptomics of 20 mouse organs creates a Tabula Muris. Nature 562, 367\u2013372 (2018).","journal-title":"Nature"},{"key":"58634_CR67","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s00401-015-1450-z","volume":"130","author":"MH Schludi","year":"2015","unstructured":"Schludi, M. H. et al. Distribution of dipeptide repeat proteins in cellular models and C9orf72 mutation cases suggests link to transcriptional silencing. Acta Neuropathol. 130, 537\u2013555 (2015).","journal-title":"Acta Neuropathol."},{"key":"58634_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2297-3","volume":"11","author":"ALS Cruz","year":"2020","unstructured":"Cruz, A. L. S., Barreto, E. A., Fazolini, N. P. B., Viola, J. P. B. & Bozza, P. T. Lipid droplets: platforms with multiple functions in cancer hallmarks. Cell Death Dis. 11, 105 (2020).","journal-title":"Cell Death Dis."},{"key":"58634_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2020.144874","volume":"756","author":"E Rassart","year":"2020","unstructured":"Rassart, E., Desmarais, F., Najyb, O., Bergeron, K. F. & Mounier, C. Apolipoprotein D. Gene 756, 144874 (2020).","journal-title":"Gene"},{"key":"58634_CR70","doi-asserted-by":"publisher","first-page":"19316","DOI":"10.1073\/pnas.0910916106","volume":"106","author":"L Abi-Mosleh","year":"2009","unstructured":"Abi-Mosleh, L., Infante, R. E., Radhakrishnan, A., Goldstein, J. L. & Brown, M. S. Cyclodextrin overcomes deficient lysosome-to-endoplasmic reticulum transport of cholesterol in Niemann-Pick type C cells. Proc. Natl. Acad. Sci. USA 106, 19316\u201319321 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"58634_CR71","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1073\/pnas.0810895106","volume":"106","author":"B Liu","year":"2009","unstructured":"Liu, B. et al. Reversal of defective lysosomal transport in NPC disease ameliorates liver dysfunction and neurodegeneration in the npc1-\/- mouse. Proc. Natl. Acad. Sci. USA 106, 2377\u20132382 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"58634_CR72","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1084\/jem.20121239","volume":"209","author":"J Yao","year":"2012","unstructured":"Yao, J. et al. Neuroprotection by cyclodextrin in cell and mouse models of Alzheimer disease. J. Exp. Med. 209, 2501\u20132513 (2012).","journal-title":"J. Exp. Med"},{"key":"58634_CR73","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1523\/JNEUROSCI.0933-21.2021","volume":"42","author":"DA Becktel","year":"2022","unstructured":"Becktel, D. A. et al. Repeated administration of 2-hydroxypropyl-beta-cyclodextrin (HPbetaCD) attenuates the chronic inflammatory response to experimental stroke. J. Neurosci. 42, 325\u2013348 (2022).","journal-title":"J. Neurosci."},{"key":"58634_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.gim.2022.11.017","volume":"25","author":"N Agrawal","year":"2023","unstructured":"Agrawal, N. et al. Neurofilament light chain in cerebrospinal fluid as a novel biomarker in evaluating both clinical severity and therapeutic response in Niemann-Pick disease type C1. Genet. Med. 25, 100349 (2023).","journal-title":"Genet. Med"},{"key":"58634_CR75","volume":"36","author":"R Sharma","year":"2023","unstructured":"Sharma, R. et al. Long-term administration of intravenous trappsol(R) Cyclo (HP-beta-CD) results in clinical benefits and stabilization or slowing of disease progression in patients with Niemann-Pick disease type C1: results of an international 48-week phase I\/II trial. Mol. Genet Metab. Rep. 36, 100988 (2023).","journal-title":"Mol. Genet Metab. Rep."},{"key":"58634_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39733-6","volume":"14","author":"TJ Kunkel","year":"2023","unstructured":"Kunkel, T. J. et al. The cholesterol transporter NPC1 is essential for epigenetic regulation and maturation of oligodendrocyte lineage cells. Nat. Commun. 14, 3964 (2023).","journal-title":"Nat. Commun."},{"key":"58634_CR77","doi-asserted-by":"crossref","unstructured":"Greensmith, L. & Bryson, J. B. The cholesterol depleting agent, (2-Hydroxypropyl)-ss-cyclodextrin, does not affect disease progression in SOD1(G93A) mice. Amyotroph. Lateral Scler. Frontotemporal. Degener. 25, 1\u20137 (2023).","DOI":"10.1080\/21678421.2023.2239867"},{"key":"58634_CR78","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1002\/jps.1062","volume":"90","author":"S Proniuk","year":"2001","unstructured":"Proniuk, S. & Blanchard, J. Influence of degree of substitution of cyclodextrins on their colligative properties in solution. J. Pharm. Sci. 90, 1086\u20131090 (2001).","journal-title":"J. Pharm. Sci."},{"key":"58634_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2020.100232","volume":"1","author":"G Kislinger","year":"2020","unstructured":"Kislinger, G. et al. ATUM-FIB microscopy for targeting and multiscale imaging of rare events in mouse cortex. STAR Protoc. 1, 100232 (2020).","journal-title":"STAR Protoc."},{"key":"58634_CR80","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/s41586-020-2649-2","volume":"585","author":"CR Harris","year":"2020","unstructured":"Harris, C. R. et al. Array programming with NumPy. Nature 585, 357\u2013362 (2020).","journal-title":"Nature"},{"key":"58634_CR81","unstructured":"Bradski. G. The OpenCV Library. Dr Dobb\u2019s Journal of Software Tools (The OpenCV Library, 2000)."},{"key":"58634_CR82","doi-asserted-by":"publisher","first-page":"e453","DOI":"10.7717\/peerj.453","volume":"2","author":"S van der Walt","year":"2014","unstructured":"van der Walt, S. et al. scikit-image: image processing in Python. PeerJ 2, e453 (2014).","journal-title":"PeerJ"},{"key":"58634_CR83","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41592-020-01018-x","volume":"18","author":"C Stringer","year":"2021","unstructured":"Stringer, C., Wang, T., Michaelos, M. & Pachitariu, M. Cellpose: a generalist algorithm for cellular segmentation. Nat. Methods 18, 100\u2013106 (2021).","journal-title":"Nat. Methods"},{"key":"58634_CR84","doi-asserted-by":"crossref","unstructured":"Martelotto, L. G. Frankenstein\u2019s protocol for nuclei isolation from fresh and frozen tissue for snRNAseq V.2. protocols.io (2020).","DOI":"10.17504\/protocols.io.3fkgjkw"},{"key":"58634_CR85","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587.e3529 (2021).","journal-title":"Cell"},{"key":"58634_CR86","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289\u20131296 (2019).","journal-title":"Nat. Methods"},{"key":"58634_CR87","doi-asserted-by":"crossref","unstructured":"Zappia, L. & Oshlack, A. Clustering trees: a visualization for evaluating clusterings at multiple resolutions. GigaScience 7, giy083 (2018).","DOI":"10.1093\/gigascience\/giy083"},{"key":"58634_CR88","doi-asserted-by":"crossref","unstructured":"Franz\u00e9n, O., Gan, L.-M. & Bj\u00f6rkegren, J. L. M. PanglaoDB: a web server for exploration of mouse and human single-cell RNA sequencing data. Database 2019, baz046 (2019).","DOI":"10.1093\/database\/baz046"},{"key":"58634_CR89","doi-asserted-by":"crossref","unstructured":"Cembrowski, M. S., Wang, L., Sugino, K., Shields, B. C. & Spruston, N. Hipposeq: a comprehensive RNA-seq database of gene expression in hippocampal principal neurons. eLife 5, e14997 (2016).","DOI":"10.7554\/eLife.14997"},{"key":"58634_CR90","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41592-019-0654-x","volume":"17","author":"RA Amezquita","year":"2020","unstructured":"Amezquita, R. A. et al. Orchestrating single-cell analysis with Bioconductor. Nat. Methods 17, 137\u2013145 (2020).","journal-title":"Nat. Methods"},{"key":"58634_CR91","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"58634_CR92","doi-asserted-by":"crossref","unstructured":"Dhingra, A. et al. Automated production of human induced pluripotent stem cell-derived cortical and dopaminergic neurons with integrated live-cell monitoring. J. Vis. Exp. 162, e61525 (2020).","DOI":"10.3791\/61525"},{"key":"58634_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110913","volume":"39","author":"M Czuppa","year":"2022","unstructured":"Czuppa, M. et al. Drug screen in iPSC-Neurons identifies nucleoside analogs as inhibitors of (G4C2)n expression in C9orf72 ALS\/FTD. Cell Rep. 39, 110913 (2022).","journal-title":"Cell Rep."},{"key":"58634_CR94","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.726866","volume":"9","author":"T Strauss","year":"2021","unstructured":"Strauss, T. et al. iPS cell-based model for MAPT haplotype as a risk factor for human tauopathies identifies no major differences in TAU expression. Front. Cell Dev. Biol. 9, 726866 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"58634_CR95","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-022-02660-8","volume":"23","author":"A Janjic","year":"2022","unstructured":"Janjic, A. et al. Prime-seq, efficient and powerful bulk RNA sequencing. Genome Biol. 23, 88 (2022).","journal-title":"Genome Biol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58634-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58634-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58634-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T08:40:54Z","timestamp":1744360854000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58634-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,11]]},"references-count":95,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["58634"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-58634-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,11]]},"assertion":[{"value":"13 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"L.R.P., N.H., and D.O. are employees of Sanofi, but Sanofi is not actively developing CD-based therapeutics. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3442"}}